04/28/2025 13:00
University of Melbourne’s Mobile Learning Unit (MLU) Selects Rimini Solutions™ for Salesforce to Manage and Enhance its eLearning Platform

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that the Mobile Learning Unit (MLU) at the University of Melbourne has selected Rimini Manage™ and Rimini Consult™ for Salesforce as its strategy to bring stability and enhancement to its eLearning platform. This press release features multimedia. View the full release here: htt...

04/28/2025 13:00
Seoul Semiconductor: Unified Patent Court Orders Recall of Products Infringing Essential Micro LED Patents

Seoul Semiconductor Co., Ltd. (KOSDAQ: 046890), a leading global innovator of LED products and technology, announced that the Local Division Paris of the Unified Patent Court (UPC), which has jurisdiction across 18 European countries, has issued a judgment that Laser Components SAS infringed Seoul Semiconductor affiliate’s core optical semiconductor patent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428172182/en/Comparison of ...

04/28/2025 13:00
Generix Announces New AI-Powered Resource Management System (RMS) to Intelligently Optimize All Warehouse Resources

Generix, a global business software company offering an expansive portfolio of SaaS solutions for supply chain, finance, commerce, and B2B integration, today announces the launch of Generix Resource Management Systems (RMS), a new AI-powered application that optimizes all warehouse resources through intelligent forecasting, planning, and analytics – all in a single environment. As many warehouse management teams struggle to keep pace with supply chain disruptions with error-prone, disparate ma...

05/14/2025 21:03
The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1

Takeda (TSE: 4502/NYSE:TAK) today announced that the New England Journal of Medicine published data from the Phase 2b trial of oveporexton (TAK-861) in people with narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to restore orexin signaling to address the underlying orexin deficiency that causes NT1. Results demonstrated significant improvement in objective and subjective measures of excessive daytime sleepiness (EDS), reduction...

05/20/2025 10:00
AHS to Launch $750 Million Casa AHS on Dubai Water Canal

AHS Properties, the UAE’s leading ultra-luxury real estate developer, has announced the launch of Casa AHS, a landmark waterfront development valued at $750 million (AED 2.75 billion). Set along the prestigious Dubai Water Canal, the project redefines elite urban living with a curated collection of exceptional residences. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520255397/en/AHS to Launch $750 Million Casa AHS on Dubai Water...